how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.
how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.
how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.
how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.
Dr. Yujie Ma - Best of the Best in Pediatric Surgery 2025
▶Ep 3 · 5:58
quotehow universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.↗
▶Ep 3 · 5:58
quotehow universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.↗
Dr. Yujie Ma - Best of the Best in Pediatric Surgery 2025
▶Ep 18 · 5:58
quotehow universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.↗
▶Ep 18 · 5:58
quotehow universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies.↗
